. Author manuscript; available in PMC: 2015 Jun 3.

Published in final edited form as: Clin Cancer Res. 2012 Sep 10;18(22):6373–6383. doi: 10.1158/1078-0432.CCR-12-1627

Table 3. Response in patients with a BRAF mutation, a mutation other than BRAF, and all patients by type of therapy (nonrandomized).

1 aberration	Type of therapy	No. of treated patients	CR/PR (%)	P
BRAF	Matched	70	26 (37)	0.004
	Nonmatched	14	0 (0)
Non-BRAF	Matched	105	21 (20)	0.003
	Nonmatched	102	6 (6)
Total	Matched	175	47 (27)	<0.0001
	Nonmatched	116	6 (5)